Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

56.71 +0.59 (+1.05%)
Streaming Delayed Price Updated: 1:21 PM EDT, Oct 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Top 4 Must-Have Healthcare Stocks for Long-Term Growth
Investing in healthcare offers long-term growth and stability fueled by demographic trends, technological advancements, and rising demand. 
Via MarketBeat
7 High-Yield Dividend Stocks to Buy and Hold Forever: July Edition
Explore the top seven high-yield dividend stocks, leading in several industries to buy and hold for income stability. 
Via InvestorPlace
3 Underdog Stocks Set to Skyrocket This Year
Unemployment at record lows and sectors growing through new business verticals make it the perfect time to look into these underdog stocks. 
Via InvestorPlace
Behind the Scenes of CVS Health's Latest Options Trends
Via Benzinga
Check Out What Whales Are Doing With CVS
Via Benzinga
Peering Into CVS Health's Recent Short Interest
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
FTC Investigation Uncovers Anti-Competitive Practices By Handful Of Pharmacy Benefit Managers, Including CVS Health, UnitedHealth
The FTC's report reveals how major PBMs like UnitedHealth, CVS, and Cigna influence drug prices, impacting small pharmacies and consumers. 
Via Benzinga
3 Bargain Stocks With the Potential for Mind-Boggling Returns
Discover three bargain stocks leading in healthcare and pharmaceuticals with fundamentals behind their potential for massive returns. 
Via InvestorPlace
The Next Blockbuster?
Like Blockbuster in the ‘80s and ‘90s, drugstores were the place to be for commercial real estate in the 2000s and early 2010s. 
Via Talk Markets
Bitcoin Dip Not Over Yet Or The Shorts Are About To Get 'Obliterated,' Says Ali Martinez
Bitcoin (CRYPTO: BTC) analyst Ali Martinez has recently shared insights on the current state of the cryptocurrency market, suggesting that the recent price action could continue. 
Via Benzinga
Is CVS Health Stock a Buy?
Are investors being overly bearish on CVS Health? 
Via The Motley Fool
Behind the Scenes of CVS Health's Latest Options Trends
Via Benzinga
3 Retail Stocks to Sell in July Before They Crash & Burn
With brick-and-mortar retail chains losing share to Amazon and many consumers struggling, there are many retail stocks to sell. 
Via InvestorPlace
Down by 25%, Can CVS Health Bounce Back in the Second Half of The Year?
There's an argument to be made that investors should cut their losses and leave, but there is more to the story. 
Via The Motley Fool
CVS, Rite Aid, Walgreens Hit Hard By Online Pharmacy Trend
Rite Aid's restructuring plan, approved by a U.S. bankruptcy judge, reduces $2 billion in debt and shifts control to lenders. Following Chapter 11 bankruptcy and $750 million in losses, the pharmacy... 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Down Over 60%, Is Walgreens Boots Alliance a Bad-News Buy?
After falling a long way, the pharmacy stock is trading at a surprisingly low valuation. 
Via The Motley Fool
What's Behind Walgreens Stock Plunge: What Investors Can Do Next
Shares of Walgreens are down over 25% in a single day, pushing investors to seek an answer. There is a lateral play that can be considered for income here 
Via MarketBeat
3 Beaten-Down Stocks Ready for a Comeback: June 2024
Discover why these beaten-down stocks resurgence despite recent challenges, and explore their fundamentals in healthcare and broadcasting. 
Via InvestorPlace
The 3 Smartest Healthcare Stocks to Buy With $1K Right Now
The healthcare stocks to buy deserve more respect from investors who seek top-level growth outside of the tech sector. 
Via InvestorPlace
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court
Cencora stock and other drug distributors fell on Wednesday, hit by Walgreens results, not the ruling that killed an opioid settlement. 
Via Investor's Business Daily
Walgreens Plans 'Significant' Store Closures As It Faces 'Difficult Operating Environment'
Major US pharma chain Walgreens to close undisclosed number of stores due to headwinds, CEO acknowledges challenges. Rite Aid also faces bankruptcy. 
Via Benzinga
Stock Of The Day: It's No Coincidence CVS Health Stock Found Support Where It Did
It isn't a coincidence that shares of CVS Health Corporation (CVS) found support where they did. It was at a former resistance level. 
Via Benzinga
Bargain Alert: 7 Long-Term Stocks to Buy Hand-Over-Fist
These seven undervalued stocks across diverse sectors present compelling long-term buying opportunities after significant selloffs. 
Via InvestorPlace
Why Is Moderna Stock Trading Lower On Wednesday?
The CDC's Advisory Committee on Immunization Practices is set to discuss recommendations for RSV, influenza, and COVID-19 vaccines. Moderna's data shows vaccine efficacy drops to 50% after 18 months in... 
Via Benzinga
Exposures COVID-19
Investors Worry How Trump Tariffs Could Further Impact Companies Reliant On Chinese Suppliers: Vulnerable Stocks 'Have Underperformed' This Year
Donald Trump proposes replacing income taxes with tariffs on foreign goods, causing skepticism from experts and impacting stocks reliant on Chinese imports. 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute
MedImpact's bid to reclaim $200 million after acquiring Rite Aid's pharmacy benefits unit has failed. U.S. Bankruptcy Judge ruled MedImpact assumed Elixir's debts in the $575 million deal. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
US Election And Tariff Prospects Set To Threaten Internationally-Exposed Stocks, Goldman Sachs Warns
Election outcome could impact USD & US firms. Betting odds favor Trump & Republican majority, which may strengthen USD & hurt intl firms. 
Via Benzinga
Topics Government
Exposures Political
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.